ClinicalTrials.gg
CompletedNCT03778190Updated Aug 26, 2020Results posted

Magnet for Corneal Foreign Bodies

An interventional study of Corneal Foreign Body Removal in Corneal Foreign Body, sponsored by Kendall Healthcare Group, Ltd.. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-08-26.

Sponsored by Kendall Healthcare Group, Ltd. · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This is a prospective, interventional study to assess the effectiveness and safety of a commercially available "eye magnet" to remove corneal foreign bodies.

Read the detailed description

The vast majority of corneal foreign bodies are metallic and thus are frequently ferromagnetic. Consequently, it may be possible to use a magnet to remove most corneal foreign bodies. There are commercially available products for removing corneal foreign bodies, but there are no published studies assessing these devices.

This will be a prospective interventional study to assess the use of an eye magnet for the removal of metallic corneal foreign bodies in the emergency department.

After the patient signs written, informed consent, the physician will attempt to remove the corneal foreign body with the North by Honeywell 326734G Eye Magnet with Loop. If the physician is unable to remove the corneal foreign body with the magnet, he or she may proceed with standard care.

The treating physician will fill out a brief data collection form for each patient to track various outcomes as discussed below.

02

Conditions studied

  • Corneal Foreign Body

Browse trials for

03

In context

Foreign Bodies

29 studies on the registry are indexed under Foreign Bodies; 8 are open to participants now.

Browse Foreign Bodies studies →

Lead sponsor

Kendall Healthcare Group, Ltd. is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • present to the emergency department with a metallic corneal foreign body

Exclusion criteria

Exclusion Criteria:

  • prisoners
  • pregnant women
  • have pacemakers or metallic facial implants
  • possible globe rupture
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (actual)

Study arms

  • Experimental
    Magnet

    The physician will attempt to remove the corneal foreign body using an eye magnet for these patients.

    Procedure: Corneal Foreign Body Removal

Interventions

  • ProcedureCorneal Foreign Body Removal

    An eye magnet will be brought close to the foreign body on the surface of the eye in an attempt to remove the foreign body.

06

What researchers measure

Primary outcomes

  1. Success Rate

    The percentage of patients in whom the magnet successfully removed the foreign body.

    Time frame: 5 minutes.

Secondary outcomes

  1. Epithelial Damage

    The percentage of patients in whom the amount of fluorescein uptake on exam was more after the procedure compared to before the procedure.

    Time frame: 5 minutes

07

Results

Posted Aug 26, 2020

Participant flow

Participant flow — Overall Study
MilestoneMagnet
Started10
Completed10
Not completed0

Outcome measures

PrimarySuccess Rate

The percentage of patients in whom the magnet successfully removed the foreign body.

Time frame:
5 minutes.
Reported as:
Count of participants · Participants
Success Rate
ParticipantsMagnet
Success Rate1
SecondaryEpithelial Damage

The percentage of patients in whom the amount of fluorescein uptake on exam was more after the procedure compared to before the procedure.

Time frame:
5 minutes
Reported as:
Count of participants · Participants
Epithelial Damage
ParticipantsMagnet
Epithelial Damage0

Adverse events

Collected over 10 minutes. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Magnet0/10 (0%)0/10 (0%)0/10 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Magnet
<=18 years0
Between 18 and 65 years10
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Magnet
Female0
Male10
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Magnet
Region of Enrollment
Region of Enrollment(Participants)Magnet
United States10
08

Study locations

1 site
  • Kendall Regional Medical Center
    Miami, Florida 33175, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03778190
Lead sponsor
Kendall Healthcare Group, Ltd.
Collaborators
Nova Southeastern University
Responsible party
Sponsor
First posted
Dec 19, 2018
Start date
Dec 4, 2018
Primary completion
Nov 11, 2019
Completion
Nov 11, 2019
Results posted
Aug 26, 2020
Last update
Aug 26, 2020

Study contacts

Tony Zitek, MD
study director · Kendall Healthcare Group, Ltd.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion